EnWave Corp (ENW)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:EnWave Corp (ENW) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013379
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EnWave Corp (EnWave) is an advanced technology company that provides industrial-scale dehydration technology for commercial applications in the pharmaceutical and food industries. It designs, constructs, markets and sells microwavevacuum biomaterial and food dehydration machines that use proprietary dehydration technologies developed by EnWave. The company introduced radiant energy vacuum (REV) as the new dehydration standard in the biological material and food sectors. EnWave has three commercial REV platforms, namely, nutraREV, which is used in the food industry; powderREV, which is used for the bulk dehydration of food cultures, probiotics and fine biochemical; and quantaREV, which is used for continuous, high-volume low-temperature drying. EnWave is headquartered in Vancouver, British Columbia, Canada.

EnWave Corp (ENW) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EnWave Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
EnWave Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
EnWave Corp, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
EnWave Enters into Licensing Agreement with Major Canadian Medical Cannabis Licensed Producer 10
EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 11
EnWave Enters into Licensing Agreement with Merck 12
EnWave Enters Into Licensing Agreement With North American Enzyme Company 13
Equity Offering 14
EnWave Raises USD7.2 Million in Public Offering of Units 14
EnWave Raises USD0.6 Million in Private Placement of Units 16
EnWave Raises USD0.14 Million in Private Placement of Shares 17
EnWave Completes Private Placement Of Units For US$7.4 Million 18
EnWave Completes Final Tranche Of Private Placement Of Shares For US$0.5 Million 19
EnWave Completes Private Placement Of Its Units For US$12.2 Million 20
EnWave Raises US$2.2 Million From Exercise Of Warrants 21
EnWave Corp – Key Competitors 22
EnWave Corp – Key Employees 23
EnWave Corp – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 25, 2017: EnWave Announces 2017 Third Quarter Consolidated Interim Financial Results 25
May 26, 2017: EnWave Announces 2017 Second Quarter Consolidated Interim Financial Results 26
Feb 24, 2017: EnWave Announces 2017 First Quarter Consolidated Interim Financial Results 27
Dec 16, 2016: EnWave Reports 2016 Annual Financial Results 28
Aug 26, 2016: EnWave Announces 2016 Third Quarter Consolidated Interim Financial Results 30
May 26, 2016: EnWave Announces First Quarterly Positive Net Income and Reports Consolidated Interim Financial Results for the Second Quarter Fiscal Year 2016 31
Feb 26, 2016: EnWave Reports Consolidated Interim Financial Results for the First Quarter Fiscal Year 2016 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
EnWave Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
EnWave Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
EnWave Corp, Deals By Therapy Area, 2011 to YTD 2017 8
EnWave Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
EnWave Enters into Licensing Agreement with Major Canadian Medical Cannabis Licensed Producer 10
EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 11
EnWave Enters into Licensing Agreement with Merck 12
EnWave Enters Into Licensing Agreement With North American Enzyme Company 13
EnWave Raises USD7.2 Million in Public Offering of Units 14
EnWave Raises USD0.6 Million in Private Placement of Units 16
EnWave Raises USD0.14 Million in Private Placement of Shares 17
EnWave Completes Private Placement Of Units For US$7.4 Million 18
EnWave Completes Final Tranche Of Private Placement Of Shares For US$0.5 Million 19
EnWave Completes Private Placement Of Its Units For US$12.2 Million 20
EnWave Raises US$2.2 Million From Exercise Of Warrants 21
EnWave Corp, Key Competitors 22
EnWave Corp, Key Employees 23
EnWave Corp, Subsidiaries 24

★海外企業調査レポート[EnWave Corp (ENW)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lantheus Medical Imaging Inc:製品パイプライン分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • GW Pharmaceuticals Plc (GWP)-製薬・医療分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • VT Holdings Co Ltd (7593):企業の財務・戦略的SWOT分析
    VT Holdings Co Ltd (7593) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • West Pharmaceutical Services Inc (WST)-医療機器分野:企業M&A・提携分析
    Summary West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and systems for packaging and delivery of injectable drugs and delivery system components for use healthcare, pharmaceuticals and consumer product industries. Its product and services include stoppers and seals fo …
  • New Silkroad Culturaltainment Limited.:企業の戦略・SWOT・財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • BaxterStorey Ltd:企業の戦略・SWOT・財務分析
    BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report Summary BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • TKH Group NV (TWEKA):企業の財務・戦略的SWOT分析
    TKH Group NV (TWEKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alliance Pipeline LP:企業の戦略的SWOT分析
    Alliance Pipeline LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Unigroup Inc
    Unigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Unigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Saint-Gobain Ltd:企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Coca-Cola Consolidated Inc (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Consolidated Inc (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Karnataka Power Corporation Ltd:企業の戦略的SWOT分析
    Karnataka Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Epic Systems Corp:企業の戦略的SWOT分析
    Epic Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析
    Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Orchids Paper Products Co (TIS):企業の財務・戦略的SWOT分析
    Orchids Paper Products Co (TIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆